Shares were up after the company announced higher-than-expected second quarter earnings last week. Mr. Ellis also said the market for spinal implants and cardiac rhythm management devices might be stabilizing.
Related Articles on Supply Chain:
Commentary: Pharmaceutical Companies More Careful About Off-Label Promotion
GE Unveils Discovery IGS 730 Interventional Imaging System at RSNA
Medtronic Sales High Despite Challenges for Heart and Spine Implants
